XML 61 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity (Tables)
12 Months Ended
Dec. 31, 2012
Equity [Abstract]  
Activity related to warrants
BioTime, as part of rights offerings and other agreements, has issued warrants to purchase its common shares. Activity related to warrants in 2012, 2011, and 2010 is presented in the table below:
 
 
 
Number of
Warrants
 
 
Per share
exercise price
 
 
Weighted
Average
Exercise Price
 
Outstanding, January 1, 2010
 
 
12,264,345
 
 
 
2.00
 
 
 
1.99
 
Granted in 2010
 
 
650,000
 
 
 
3.00 - 10.00
 
 
 
6.77
 
Exercised in 2010
 
 
(12,240,357
)
 
 
1.818 - 2.00
 
 
 
1.87
 
Exercised in 2010
 
 
(24,988
)
 
 
2.00
 
 
 
2.00
 
Outstanding, December 31, 2010
 
 
649,000
 
 
 
.68 - 10.00
 
 
 
6.42
 
Granted in 2011
 
 
206,613
 
 
 
10.00
 
 
 
10.00
 
Exercised in 2011
 
 
(219,000
)
 
 
.68 - 3.00
 
 
 
1.94
 
Outstanding, December 31, 2011
 
 
636,613
 
 
$
3.00 – 10.00
 
 
$
9.13
 
Expired in 2012
 
 
(80,000
)
 
 
3.00
 
 
 
3.00
 
Outstanding, December 31, 2012
 
 
556,613
 
 
$
10.00
 
 
$
10.00
 
 
Summary of stock option activity for subsidiaries
A summary of all option activity under the 2007, 2010, and 2011 subsidiary option plans for subsidiaries (see Note 10) for the years ended December 31, 2012 and 2011 is as follows:
 
 
 
Options
Available for
Grant
 
 
Number of
Options
Outstanding
 
 
Weighted
Average
Exercise Price
 
January 1, 2011
 
 
7,703,060
 
 
 
4,312,640
 
 
$
0.74
 
Added upon adoption of option plan in 2011
 
 
8,000,000
 
 
 
-
 
 
 
-
 
Granted in 2011
 
 
(4,685,000
)
 
 
4,685,000
 
 
 
0.36
 
Forfeited/Exercised in 2011
 
 
200,000
 
 
 
(200,000
)
 
 
0.05
 
December 31, 2011
 
 
11,218,060
 
 
 
8,797,640
 
 
$
0.56
 
Reverse stock split and change in plan in 2012
 
 
(3,697,014
)
 
 
(2,460,717
)
 
 
-
 
Granted in 2012
 
 
(1,479,490
)
 
 
1,479,490
 
 
 
1.39
 
Forfeited/Exercised in 2012
 
 
-
 
 
 
-
 
 
 
-
 
December 31, 2012
 
 
6,041,556
 
 
 
7,816,413
 
 
$
0.93